Urinary Incontinence Treatment Devices Market

Global Urinary Incontinence Treatment Devices Market Size (2023 to 2028)

The global market size for urinary incontinence treatment devices is forecasted to grow at a CAGR of 8.02% from 2023 to 2028 and be worth USD 5.08 billion by 2028 from USD 3.45 billion in 2023.

Incontinence refers to any involuntary urine leakage. The most prevalent reasons for male urinary incontinence are a damaged sphincter or a faulty bladder. The bladder's sphincter is a circular muscle that controls urine flow. This muscle loses its capacity to squeeze and close the urethra, which transfers pee from the bladder to the outside of the body when it is injured. Urinary incontinence devices aid in collecting and holding urine and treating urinary incontinence. Urinary incontinence is a condition in which urine leaking is uncontrollable.

Impact of COVID-19 on the global urinary incontinence treatment devices market:

The COVID-19 pandemic has disrupted healthcare workflows all across the globe. The overall impact of the COVID-19 pandemic remained adverse for key players in the urinary incontinence market. Outpatient clinics for female urinary incontinence, benign prostatic hyperplasia, infertility and sexual medicine, benign scrotal conditions, renal stone, and bladder stone were the most affected, according to a 2020 research study by Jeremy Yuen-Chun Teoh et al. titled 'A Global Survey on the Impact of COVID-19 on Urological Services.' As a result of the pandemic, outpatient visits were canceled, and non-emergency hospitalizations and treatments were discontinued. As a result, the number of urological visits and treatments requiring routine clinical evaluations has decreased.

MARKET DRIVERS:

The increased prevalence of urinary incontinence is a primary factor accelerating the expansion of the global urinary incontinence treatment devices market.

Urinary incontinence symptoms can be caused by various reasons, including urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and radical prostatectomy surgery in males. Furthermore, the market is expected to rise due to the rising demand for minimally invasive procedures and technological advances. In addition, increased research and development in user interfaces are raising public awareness and offering chances for the studied market, projected to drive the market's growth. Furthermore, market players employ various methods, such as product releases, developments, acquisitions, mergers, and partnerships, to increase their product portfolio in the market under consideration, accelerating market growth.

The market for urine incontinence treatment devices is further expected to rise due to the increased prevalence of urological problems and the development of improved urinary incontinence devices. In addition, the number of patients with urine incontinence who are abandoning traditional techniques is projected to climb in the near future. Furthermore, an increase in healthcare spending in developing countries is likely to create new growth opportunities. Advancements in catheter technology are credited with driving the global market for urinary incontinence treatment devices.

MARKET RESTRAINTS:

Over the forecast period, factors such as a lack of awareness about devices and the social stigma associated with the disease, as well as the risks and complications related to the procedures, are expected to hamper the market growth. In addition, the global urinary incontinence treatment devices market is projected to be hindered by certain factors, such as the risk of urine leakage due to device failure.

REPORT COVERAGE:

This research report on the global urinary incontinence devices market has been segmented and sub-segmented based on product, type, end-user, and region.

Urinary Incontinence Treatment Devices Market – By Product:

• Urethral Slings
• Electrical Stimulation Devices
• Artificial Urinary Sphincters
• Catheters and Others

The market for urethral slings is predicted to expand, as these are highly recommended for surgical treatment of stress urinary incontinence. The sling material utilized in urethral sling surgery, also known as mid-urethral sling surgery, can be muscle, ligament, or tendon tissue obtained from the woman or an animal, such as a pig. It could also be made of a synthetic substance compatible with bodily tissues, such as plastic or an absorbable polymer that dissolves over time.

Urinary Incontinence Treatment Devices Market – By Type:

• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Overflow Urinary Incontinence
• Mixed Incontinence

The urge incontinence segment is expected to dominate the global urinary incontinence treatment market during the forecast period. Overactive bladder affects a large number of people all over the world, resulting in incontinence. The strength of the urge incontinence segment is due to the higher cost of treatment devices, notably implantable electrical stimulation devices, compared to other treatment devices. As a result, an increase in the rate of urge incontinence, an increase in the selection of electrical incontinence devices for overactive bladder therapy, and new product launches in the market are expected to contribute to the segment's growth during the forecast period.

Urinary Incontinence Treatment Devices Market – By End-User:

• Hospitals
• Clinics

Based on the end-user, the hospitals segment accounted for the most significant proportion of the global market in 2021. During the forecast period, an increase in the number of multinational hospitals with advanced sling surgery procedures such as TVT and TOT and the use of small slings.

Urinary Incontinence Treatment Devices Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Because of its well-developed healthcare infrastructure and high public awareness of medical advances, North America is expected to be the primary market for stress urinary incontinence treatment devices. In addition, the increasing prevalence of urine incontinence (UI), the growing senior population, and the rising desire for minimally invasive surgeries in the region contribute to market expansion in the North American region.

Throughout the forecast period, Asia-Pacific is expected to grow at a fast rate. Due to its large population, rising disposable incomes, and increased patient knowledge of advanced urinary incontinence care, the region presents an attractive potential for urinary incontinence device manufacturers. In Asia-Pacific, Japan, India, and China are among the nations with the highest prevalence of urine incontinence, contributing to the region's strong performance in the worldwide urinary incontinence device market. In addition, changes in lifestyle and demographics have increased the number of females experiencing gynecological disorders at a younger age.

Due to new product development and launch in international markets, Europe was the second leading market for stress urinary incontinence treatment devices.

Government reimbursement systems in both developed and developing markets are projected to present opportunities in the worldwide stress urinary incontinence treatment devices market, as Latin America has assisted the development of healthcare infrastructure in these regions.

KEY MARKET PARTICIPANTS:

Becton, Dickinson and Company, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc. (Cook Medical Inc.), Johnson & Johnson (Ethicon Inc.), Laborie Medical (Cogentix Medical Inc.), Medtronic plc and Teleflex Incorporated are some of the noteworthy companies operating in the global urinary incontinence treatment devices market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• BladderCell began a bioelectric treatment clinical study for incontinence in 2020, which will include pelvic stimulation. 
• ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter models have recently acquired CE Mark Approval and will be accessible in all major European markets in 2020, according to Rigicon.